Eiko LifeSciences Limited

NIDL

INE666Q01016

Diversified Chemicals

Market Closed - Bombay S.E. Other stock markets 03:30:56 31/05/2024 pm IST			5-day change	1st Jan Change
51.96 ^INR	+3.71%		+4.15%	-18.89%

31/05	Eiko Lifesciences Forms New Limited Liability Partnership	MT
13/05	Eiko LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Eiko Lifesciences Limited Approves Appointment of Company Secretary and Compliance Officer

November 08, 2023 at 07:16 pm IST

The board of directors of Eiko LifeSciences Limited meeting held on November 8, 2023, approved appointment of Mr. Chintan B. Doshi as Company Secretary and Compliance Officer, pursuant to section 203 of the Companies Act, 2013 and Regulation 6(1) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 with immediate effect. Education Qualification: Company Secretary (ICSI).

Latest news about Eiko LifeSciences Limited

Eiko Lifesciences Forms New Limited Liability Partnership	31/05	MT
Eiko LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	13/05	CI
Eiko LifeSciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024	13/05	CI
Eiko Lifesciences Completes Acquisition of 25% Stake in Reflux Pharmaceuticals	19/04	MT
Eiko LifeSciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02	CI
Eiko Lifesciences Limited Enters into Definitive Business Agreement with Vivacious Pharmatex Private Limited	25/01	CI
Eiko Lifesciences Limited Approves Appointment of Company Secretary and Compliance Officer	08/11	CI
Eiko LifeSciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	08/11	CI
Eiko Lifesciences Limited Announces Resignation of Nilima Burghate as Company Secretary and Compliance Officer	30/23/30	CI
Eiko LifeSciences Limited Approves Appointment of Nilima A. Burghate as Company Secretary and Compliance Officer	12/23/12	CI
Eiko LifeSciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Eiko LifeSciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Eiko Lifesciences Limited Announces Resignation of Avi Vijaykumar Mundecha as Company Secretary and Compliance Officer	18/23/18	CI
Eiko Lifesciences to Acquire Minority Stake in Reflux Pharmaceuticals	18/23/18	MT
Eiko LifeSciences Limited Reports Earnings Results for the Full Year Ended March 31, 2023	09/23/09	CI
Eiko LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	09/23/09	CI
Eiko Lifesciences Completes Acquisition of Minority Stake in Vivacious Pharmatex	27/23/27	MT
Eiko LifeSciences Limited completed the acquisition of 5% interest in Vivacious Pharmatex Private Limited from existing shareholders cum Directors.	25/23/25	CI
Eiko Lifesciences to Acquire Minority Stake in Vivacious Pharmatex	17/23/17	MT
Eiko LifeSciences Limited signed the Memorandum of Understanding cum Share Purchase Agreement to acquire 5% interest in Vivacious Pharmatex Private Limited from existing shareholders cum Directors for INR 0.51 million.	17/23/17	CI
Eiko LifeSciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	17/23/17	CI
Eiko Lifesciences Limited Announces Foray into Manufacturing of New Segment of Specialty Chemicals Business	30/22/30	CI
Eiko Lifesciences Signs MOU with Delicare Lifesciences for Use of Manufacturing Facilities	29/22/29	MT
Eiko LifeSciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	12/22/12	CI
Eiko LifeSciences Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22/22/22	CI

Chart Eiko LifeSciences Limited

Duration

Period

More charts

Company Profile

Eiko LifeSciences Limited is an India-based company engaged in manufacturing, processing, formulating, producing, buying, selling, and exporting specialty and fine chemicals. The Company operates through five segments: Agrochemicals, Skin Care, Cosmetics, Food Additives, and Pharmaceutical. The products manufactured by the Company are used in pharmaceutical and agrochemical industries with various end use applications including corrosion control, photographic chemicals, solvents, and corrosion inhibitors amongst others. The Company's factory is located in Badlapur, Thane District. The manufacturing facility is spread across 41,920 square meters.

Sector

Diversified Chemicals

Calendar

12/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diversified Chemicals

	1st Jan change	Capi.
EIKO LIFESCIENCES LIMITED	-18.89%	8.63M
SHIN-ETSU CHEMICAL CO., LTD.	-1.05%	74.34B
BASF SE	-0.76%	46.86B
DUPONT DE NEMOURS, INC.	+6.80%	34.35B
PIDILITE INDUSTRIES LIMITED	+9.37%	18.1B
EASTMAN CHEMICAL COMPANY	+12.81%	11.92B
SYENSQO SA/NV	-3.01%	10.43B
BRENNTAG SE	-20.72%	10.33B
ASAHI KASEI CORPORATION	-1.35%	9.04B
SRF LIMITED	-11.01%	7.84B